Prices delayed by at least 15 minutes | Print
Hutchmed (China) Limited (HCM)
ORD USD0.10This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolioof several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Address
Ugland House
P.O. Box 309
Grand Cayman
CYM
KY1-1104
Telephone
+852 21281188
Forecast key dates
| Name | Key Date |
|---|---|
| HUTCHMED (China) Ltd Annual General Meeting for 2025 | 2026-05-13T09:00:00 |
| HUTCHMED (China) Ltd Fourth Quarter Earnings Conference Call for 2025 | 2026-03-19T08:00:00 |
| HUTCHMED (China) Ltd Fourth Quarter Earnings Results for 2025 | 2026-03-19T00:00:00 |
| HUTCHMED (China) Ltd Annual Report for 2025 | 2026-03-19T00:00:00 |
| HUTCHMED (China) Ltd Second Quarter Earnings Conference Call for 2025 | 2025-07-31T08:00:00 |
| HUTCHMED (China) Ltd Second Quarter Earnings Results for 2025 | 2025-07-31T07:00:00 |
| HUTCHMED (China) Ltd Annual General Meeting for 2024 | 2025-05-13T09:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| HUTCHMED (China) Ltd Annual General Meeting for 2024 | 2025-05-13T09:00:00 |
| HUTCHMED (China) Ltd Fourth Quarter Earnings Conference Call for 2024 | 2025-03-19T08:00:00 |
| HUTCHMED (China) Ltd Fourth Quarter Earnings Results for 2024 | 2025-03-19T07:00:00 |
| HUTCHMED (China) Ltd Annual Report for 2024 | 2025-03-19T00:00:00 |
| Deutsche Bank's Depositary Receipts Virtual Investor Conference | 2024-09-24T09:00:00 |
| HUTCHMED (China) Ltd Second Quarter Earnings Conference Call for 2024 | 2024-07-31T08:00:00 |
| HUTCHMED (China) Ltd Second Quarter Earnings Results for 2024 | 2024-07-31T07:00:00 |
| R&D update 2024 | 2024-07-09T20:30:00 |
| Goldman Sachs 45th Annual Global Healthcare Conference, Miami | 2024-06-10T09:20:00 |
| Jefferies Global Healthcare Conference, New York | 2024-06-05T17:30:00 |
| BofA Securities Healthcare Conference 2024, Las Vegas | 2024-05-14T14:20:00 |
| HUTCHMED (China) Ltd Annual General Meeting for 2023 | 2024-05-10T10:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.